Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 USD | -2.30% |
|
-0.67% | +21.12% |
| Market Cap | 41.27M 36.18M 33.44M 30.76M 58.03M 3.98B 58.96M 400M 157M 1.95B 155M 152M 6.71B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 39.95M 35.02M 32.37M 29.77M 56.17M 3.85B 57.07M 387M 152M 1.89B 150M 147M 6.49B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.30% | ||
| 1 week | -0.67% | ||
| Current month | -8.59% | ||
| 1 month | -10.62% | ||
| 3 months | -27.17% | ||
| 6 months | -16.76% | ||
| Current year | +21.12% |
| 1 week | 1.42 | 1.62 | |
| 1 month | 1.42 | 1.8 | |
| Current year | 1.03 | 2.4 | |
| 1 year | 0.77 | 2.4 | |
| 3 years | 0.44 | 3.54 | |
| 5 years | 0.44 | 10.5 | |
| 10 years | 0.44 | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.30% | -0.67% | +73.24% | -36.60% | 41.27M | ||
| -3.23% | -3.76% | +89.08% | +453.14% | 37.61B | ||
| -0.66% | +1.73% | +15.49% | +28.71% | 23.08B | ||
| -2.38% | -1.14% | -22.47% | -40.11% | 7.5B | ||
| -2.43% | -4.15% | +5.55% | +79.63% | 4.77B | ||
| -0.19% | -3.11% | +13.69% | +47.83% | 2.93B | ||
| -2.53% | +0.92% | +128.21% | -17.26% | 1.85B | ||
| -4.46% | -5.01% | -22.11% | +698.03% | 1.8B | ||
| +1.21% | +3.37% | -9.74% | -62.11% | 1.83B | ||
| +7.53% | +2.54% | +31.12% | +9.23% | 1.77B | ||
| Average | -0.94% | -0.78% | +30.20% | +116.05% | 8.32B | |
| Weighted average by Cap. | -1.97% | -1.26% | +46.21% | +229.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.13M 38.02M 34.97M 65.98M 4.53B 67.03M 455M 178M 2.21B 176M 172M 7.63B | 38.73M 33.95M 31.38M 28.86M 54.45M 3.73B 55.32M 375M 147M 1.83B 145M 142M 6.3B |
| Net income | 6.7M 5.87M 5.43M 4.99M 9.42M 646M 9.57M 64.93M 25.45M 316M 25.17M 24.62M 1.09B | 24.58M 21.54M 19.91M 18.31M 34.55M 2.37B 35.11M 238M 93.33M 1.16B 92.28M 90.27M 3.99B |
| Net Debt | 4.4M 3.85M 3.56M 3.27M 6.18M 424M 6.28M 42.58M 16.69M 207M 16.5M 16.14M 714M | -1.32M -1.16M -1.07M -985K -1.86M -127M -1.89M -12.81M -5.02M -62.38M -4.96M -4.86M -215M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | $1.490 | -2.30% | 4,423 |
| 26-07-17 | $1.525 | -1.61% | 2,060 |
| 26-07-16 | $1.550 | -4.32% | 2,594 |
| 26-07-15 | $1.620 | 0.00% | 800 |
| 26-07-14 | $1.620 | +8.00% | 1,035 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
















